Scholar Rock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Scholar Rock and other ETFs, options, and stocks.

About SRRK

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. 

CEO
David L. Hallal
CEODavid L. Hallal
Employees
289
Employees289
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2012
Founded2012
Employees
289
Employees289

SRRK Key Statistics

Market cap
5.24B
Market cap5.24B
Price-Earnings ratio
-12.85
Price-Earnings ratio-12.85
Dividend yield
—
Dividend yield—
Average volume
1.52M
Average volume1.52M
High today
$43.80
High today$43.80
Low today
$42.76
Low today$42.76
Open price
$43.15
Open price$43.15
Volume
905.24K
Volume905.24K
52 Week high
$61.76
52 Week high$61.76
52 Week low
$34.25
52 Week low$34.25

Stock Snapshot

The current Scholar Rock(SRRK) stock price is $42.98, with a market capitalization of 5.24B. The stock trades at a price-to-earnings (P/E) ratio of -12.85.

On 2026-11-16, Scholar Rock(SRRK) stock moved within a range of $42.76 to $43.80. With shares now at $42.98, the stock is trading +0.5% above its intraday low and -1.9% below the session's peak.

Trading volume for Scholar Rock(SRRK) stock has reached 905.24K, versus its average volume of 1.52M.

The stock's 52-week range extends from a low of $34.25 to a high of $61.76.

The stock's 52-week range extends from a low of $34.25 to a high of $61.76.

SRRK News

Investing.com 8h
Scholar Rock at UBS Global Biopharma Conference 2026: early launch gains - Investing.com

...

Scholar Rock at UBS Global Biopharma Conference 2026: early launch gains - Investing.com
TipRanks 4d
Scholar Rock downgraded to Peer Perform from Outperform at Wolfe Research

Wolfe Research analyst Kalpit Patel downgraded Scholar Rock (SRRK) to Peer Perform from Outperform without a price target citing outperformance over the past y...

TipRanks 6d
Scholar Rock Agrees to Sell Priority Review Voucher

Scholar Rock Holding ( (SRRK) ) just unveiled an announcement. On September 11, 2026, the FDA approved ISEMBYLD, and Scholar Rock’s U.S. launch was underway du...

Analyst ratings

89%

of 18 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own SRRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.